Atrium Health Cabarrus (biopsy only)

Concord, North Carolina 28025

1 studies enrolling now · 2 studies all time

What they study most

HER2-positive Breast Cancer, Urothelial Carcinoma

Studies at this site

• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling